Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.0782
+0.0014 (1.82%)
At close: Aug 13, 2025, 4:00 PM
0.0761
-0.0021 (-2.69%)
Pre-market: Aug 14, 2025, 8:42 AM EDT
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 506 employees as of December 31, 2024. The number of employees increased by 57 or 12.69% compared to the previous year.
Employees
506
Change (1Y)
57
Growth (1Y)
12.69%
Revenue / Employee
$128,626
Profits / Employee
-$335,486
Market Cap
20.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ADAP News
- 1 day ago - Adaptimmune Reports Q2 Financial Results and Provides Business Update - Newsfile Corp
- 17 days ago - Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds - Newsfile Corp
- 3 months ago - Adaptimmune Therapeutics plc (ADAP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Adaptimmune Reports Q1 Financial Results and Provides Business Update - Newsfile Corp
- 3 months ago - Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025 - Newsfile Corp
- 5 months ago - Adaptimmune Therapeutics plc (ADAP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Adaptimmune Provides Q4 and Full Year 2024 Business Update - Newsfile Corp
- 5 months ago - Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025 - Newsfile Corp